LAVA Therapeutics Stock Forecast

Stock Price Forecast

The 3 analysts with 12-month price forecasts for LAVA Therapeutics stock have an average target of 3.33, with a low estimate of 2.00 and a high estimate of 6.00. The average target predicts an increase of 249.06% from the current stock price of 0.95.

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$2.00	$3.33	$2.00	$6.00
Change	+109.64%	+249.06%	+109.64%	+528.93%

* Price targets were last updated on Dec 20, 2024.

Analyst Ratings

The average analyst rating for LAVA Therapeutics stock from 3 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Sep '24	Oct '24	Nov '24	Dec '24	Jan '25	Feb '25
Strong Buy	1	1	1	1	1	1
Buy	1	1	1	0	0	0
Hold	0	0	0	2	2	2
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	2	2	2	3	3	3

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Arthur He HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Maintains $6 → $2	Strong Buy	Maintains	$6 → $2	+109.64%	Dec 20, 2024
Daina Graybosch Leerink Partners	Leerink Partners	Buy → Hold Downgrades $11 → $2	Buy → Hold	Downgrades	$11 → $2	+109.64%	Dec 12, 2024
Reni Benjamin JMP Securities	JMP Securities	Buy → Hold Downgrades $6	Buy → Hold	Downgrades	$6	+528.93%	Dec 11, 2024
Reni Benjamin JMP Securities	JMP Securities	Buy Reiterates $6	Buy	Reiterates	$6	+528.93%	Aug 21, 2024
Arthur He HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $6	Strong Buy	Reiterates	$6	+528.93%	Jun 28, 2024

More Analyst Ratings

Financial Forecast

Revenue This Year

7.90M

from 6.77M

16.68%

from 6.77M

Revenue Next Year

n/a

from 7.90M

EPS This Year

-1.17

from -1.57

EPS Next Year

-1.38

from -1.17

Fiscal Year	FY 2019	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Jan 1, 2020	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	-	3.75M	5.35M	19.39M	6.77M	7.90M	-	-
Revenue Growth	-	-	42.78%	262.45%	-65.09%	16.68%	-	-
EPS	-21.65	-39.90	-2.14	-1.23	-1.57	-1.17	-1.38	-1.06
EPS Growth	-	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	6	6	5

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2024	2025	2026
High	12.6M	n/a	n/a
Avg	7.9M	n/a	n/a
Low	n/a	n/a	n/a

Revenue Growth

Revenue Growth	2024	2025	2026
High	86.0%	-	-
Avg	16.7%	-	-
Low	-	-	-

EPS Forecast

EPS	2024	2025	2026
High	-0.99	-0.96	-0.62
Avg	-1.17	-1.38	-1.06
Low	-1.48	-1.55	-1.50

EPS Growth

EPS Growth	2024	2025	2026
High	-	-	-
Avg	-	-	-
Low	-	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.